期刊文献+

miR-599在宫颈癌患者中的表达变化及其预后价值研究 被引量:1

Expression and prognostic value of miR-599 in patients with cervical cancer
下载PDF
导出
摘要 目的探讨miR-599的表达对于宫颈癌患者临床病理及预后的价值。方法选取2018年1月至2021年1月本院收治的宫颈癌患者60例,收集患者癌组织标本及癌旁组织标本,以定量荧光检测法检测两者miR-599表达水平,使用CCK-8法检测细胞的增殖和侵袭能力,统计患者的不同miR-599水平表达与临床病理参数、预后生存率之间的关系。结果宫颈癌患者癌性组织内miR-599的表达明显高于癌旁正常组织,差异有统计学意义(P<0.05);miR-599的表达与宫颈癌FIGO分期、宫颈癌病理组织分化有关(P<0.05);在下调Hela细胞中的miR-599表达后,采用CCK-8法从第48小时开始,Hela细胞的增殖能力明显低于对照组(P<0.05),侵袭下室的细胞数明显少于对照组(P<0.05);miR 599高表达者3年期存活率低于低表达者(P<0.05)。结论宫颈癌患者癌性组织中miR-599的表达明显高于非癌组织,miR-599的表达与病理组织分化、细胞的增殖与侵袭能力、患者存活率密切相关,可作为诊断及治疗中的预测因子。 Objective To investigate the value of miR-599 expression in clinicopathology and prognosis of cervical cancer.Methods 60 pa-tients with cervical cancer admitted to our hospital from January 2018 to January 2021were selected.The samples of cancer tissues and adjacent tis-sues were collected.The expression levels of miR-599 were detected by quantitative fluorescence detection.The proliferation and invasion ability of cells were detected by CCK-8 method.The relationship between the expression of different miR-599 levels in patients with clinicopathological pa-rameters,prognosis and survival rate.Results The expression of miR-599 in cervical cancer tissues was significantly lower than that in adjacent nor-mal tissues(P<0.05),the expression of miR-599 was related to FIGO stage and pathological differentiation of cervical cancer(P<0.05);after down regulating the expression of miR-599 in Hela cells,CCK-8 method was used to detect the proliferation of Hela cells from the 48 h(P<0.05),while the number of cells invading the inferior chamber was significantly lower than that in the control group(P<0.05);the 3-year survival rate of high ex-pression of miR-599 was lower than that of low expression group(P<0.05).Conclusion The expression of miR-599 in cancerous tissues of cervi-cal cancer patients is significantly lower than that in non cancerous tissues.The expression of miR-599 is closely related to pathological differentia-tion,cell proliferation and invasion,and survival rate of patients,which can be used as a predictor in diagnosis and treatment.
作者 张瑜 任春娜 刘婵娟 宫玉凤 ZHANG Yu;REN Chunna;LIU Chanjuan;GONG Yufeng(Department of Laboratory Medicine,the Second Affiliated Hospital of Mudanjiang Medical College,Mudanjiang,Heilongjiang,157000,China)
出处 《当代医学》 2022年第7期10-13,共4页 Contemporary Medicine
基金 黑龙江省卫生健康委科研课题(2020-393)。
关键词 miR-599 宫颈癌患者 预后 价值研究 miR-599 Cervical cancer patients Prognosis Value research
  • 相关文献

参考文献11

二级参考文献48

  • 1余健,张国楠,谢瑞梦,樊英,田昌英.宫颈癌术后复发60例临床分析[J].中国实用妇科与产科杂志,2005,21(3):161-162. 被引量:10
  • 2BurzawaJ, Gonzales N, Frumovitz M. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma[J]. Expert Rev Anticancer Ther, 2015, 15(7):805--810.
  • 3Bartel DP. MicroRNAs: target recognition and regulatory func- tions[J]. Cell, 2009, 136(2):215-233.
  • 4Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact[J] Clin Oncol, 2009, 27(34):5848-5856.
  • 5Hagman Z, Lame O, Edsj6 A, et al. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions[J]. IntJ Cancer, 2010, 127(12):2768--2776.
  • 6Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing[J]. Cell, 2007, 129(7):1401-1414.
  • 7CanneU IG, Kong YW, Johnston SJ, et al. p38 MAPKJMK2-me- diated induction of miR-34c following DNA damage prevents Myc--dependent DNA replication[J]. Proc Nail Acad Sci U S A, 2010, 107(12):5375-5380.
  • 8Luan S, Sun L, Huang F. MicroRNA-34a: a novel tumor sup- pressor in p53-mutant glioma cell line U251[J]. Arch Med Res, 2010, 41(2):67--74.
  • 9Iorio MY, Croce CM. MicroRNAs in cancer: small molecules with a huge impact[J]. J Clin Oncol, 2009, 27(34):5848--5856.
  • 10Liu F, Wang X, LiJ, et al. miR--34c--3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer[J]. Cell Prolif, 2015, 48(5):582-592.

共引文献80

同被引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部